GRCE vs MRVL · $35.0M cap vs P/E 100, rev $5.16B
Grace Therapeutics, Inc. (GRCE) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
GRCE does not have a complete income-statement cache yet.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
GRCE currently screens at market cap $35.0M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the GRCE and MRVL stock pages for the full models.
Not investment advice.